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Background: The term meningoencephalocele (MEC) describes a herniation of cerebral tissue and meninges through a
defect in the cranium, whereas a meningocele (MC) is a herniation of the meninges alone.
Hypothesis/Objectives: To describe the clinical features, magnetic resonance imaging (MRI) characteristics, and outcomes
of dogs with cranial MC and MEC.
Animals: Twenty-two client-owned dogs diagnosed with cranial MC or MEC.
Methods: Multicentric retrospective descriptive study. Clinical records of 13 institutions were reviewed. Signalment, clini-
cal history, neurologic findings and MRI characteristics as well as treatment and outcome were recorded and evaluated.
Results: Most affected dogs were presented at a young age (median, 6.5 months; range, 1 month – 8 years). The most
common presenting complaints were seizures and behavioral abnormalities. Intranasal MEC was more common than parietal
MC. Magnetic resonance imaging identified meningeal enhancement of the protruded tissue in 77% of the cases. Poren-
cephaly was seen in all cases with parietal MC. Cerebrospinal fluid (CSF) analysis identified mild abnormalities in 4 of 11
cases. Surgery was not performed in any affected dog. Seventeen patients were treated medically, and seizures were ade-
quately controlled with anti-epileptic drugs in 10 dogs. Dogs with intranasal MEC and mild neurologic signs had a fair prog-
nosis with medical treatment.
Conclusion and clinical importance: Although uncommon, MC and MEC should be considered as a differential diagnosis
in young dogs presenting with seizures or alterations in behavior. Medical treatment is a valid option with a fair prognosis
when the neurologic signs are mild.
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Malformations of the skull include incomplete clo-sure of the calvaria. This opening of the cranium,
termed cranioschisis, is a potential gap in the skull
through which tissue can protrude. A meningoen-
cephalocele (MEC) is a protrusion of cerebral tissue
and meninges through a cranial defect, whereas a
meningocele (MC) is a herniation of the meninges
only.1 The prevalence of cranial MC and MEC in dogs
currently is unknown, and there are only 4 case reports
described. The reported dogs had different etiologies
(likely congenital and acquired after skull fracture), dif-
ferent ages at presentation (neonatal to 6 years old),
different localizations of the MC or MEC (1 parietal, 3
intranasal), and variability in the severity of clinical
signs and outcomes.2–5
In human medicine, the prevalence of congenital
MEC is approximately 1/40,000 births.6 Severe MECs
are diagnosed prenatally or at birth, whereas discrete
MECs may only cause clinical signs at an adult age.
They are classified according to the anatomic localiza-
tion of the skull defect.7 Fronto-ethmoidal MECs pro-
truding into the nasal cavity are named intranasal
MECs. Many patients with intranasal MEC present
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without any neurologic signs, and only with signs of
nasal obstruction or rhinorrhea.8 If neurologic deficits
are observed, they mostly consist of seizures.9 The
imperative for surgical treatment is strong in all
patients.10 Outcome is largely dependent on the local-
ization of the skull defect and the content of the herni-
ated sac (infants with a large sac have a worse
outcome).11
The aim of our study was to expand the current
knowledge of MECs and MCs by reporting the clinical
presentation, imaging features, treatment, and outcome
of a large case series of canine cases. We hypothesized
that, although a MEC may be an epileptic focus, dogs
with mild-to-moderate neurologic signs may respond to
medical management alone.
Material and Methods
Study Design
The clinical records of dogs presented to several neurology
referral centers between 2006 and 2016 and diagnosed with cranial
MC or MEC were retrospectively analyzed. Ethical approval was
granted from the University of Glasgow for this study (Ref 31a/
15).
Inclusion criteria included complete neurologic examination,
diagnosis of cranial MC or MEC, MRI of the brain, and sufficient
clinical information available for review.
The following information was recorded for each case: signal-
ment, presenting complaint, duration of clinical signs, seizure
type if applicable, and findings on physical and complete neuro-
logic examinations at presentation. Results of MRI and CSF
examination also were evaluated. Treatment, outcome (duration
of follow-up period, frequency of seizures, reason for euthana-
sia), and necropsy results (if applicable) were recorded. Dogs
were classified as responders if they experienced a ≥ 50%
decrease in seizure frequency from baseline or absence of
seizures,12 when data were available, or as improved signs and
controlled seizures, if data were insufficient to determine whether
a 50% decrease in seizure frequency was achieved, but owners
reported that seizure frequency was decreased and quality of life
was adequate.
Magnetic resonance imaging was performed with scanners of
variable field strength (0.2 T–3.0 T). Anesthetic protocols and
patient positioning varied according to the neurology center. All
studies included spin-echo or turbo spin-echo T2-weighted sagittal
and transverse views, both pre- and postcontrast (gadopentetate
dimeglumine) spin-echo or turbo spin-echo T1-weighted transverse
views and T2-weighted fluid-attenuation inversion recovery
(FLAIR) transverse views. Some of these studies included short
tau inversion recovery sequences, gradient recall echo (GRE)
transverse views, spin-echo or turbo spin-echo T2-weighted dorsal
views, pre- and postcontrast spin-echo or turbo spin-echo T1-
weighted dorsal and sagittal views and FLAIR dorsal views.
One board-certified veterinary neurologist (RGQ), blinded to
signalment and neurologic examination, retrospectively reviewed
and described the MRI findings for each case. The following cri-
teria were recorded: affected bone, protrusion of meninges alone
or meninges and cerebral tissue, hyperintensity of protruded tis-
sue on T2-weighted images compared to normal gray matter,
presence of fluid in the meningeal sac, presence of a signal void
on GRE sequences in the protruding tissue (whenever sequence
was available), presence of meningeal enhancement of the pro-
truding meninges after contrast administration, presence of other
intracranial MRI findings and concurrent malformations, asym-
metry of nonprotruded brain tissue (characterized by cranial dis-
placement of the lateral ventricle, distortion of the corpus
callosum, or both), and presence of a unilateral or bilateral
protrusion.
For the intranasal MEC, the amount of protruding tissue was
subjectively classified with a 3-point grading scale (mild, moder-
ate, and severe) dependent on the amount of tissue protruding
through the cranial defect on the basis of dorsal T2-weighted
images at the level of maximum protrusion as a consensus
between 2 observers, RGQ and 1 European College of Veterinary
Neurology (ECVN) residency-trained neurologist (JG). Dorsal T1-
weighted images were used if T2-weighted images were not avail-
able. Subjective assessment, which is likely to be the method
employed in a clinical setting to determine MEC size, was com-
pared with a quantitative measurement of MEC volume. To allow
comparison among dogs of different sizes, volume ratio between
protruded brain tissue and intracalvarial brain tissue was calcu-
lated. Three-dimensional visualization of the normal brain and
MEC was performed in all cases with intranasal MEC by the
software Amiraa based on T2-weighted transverse images
(Fig. S1). Volume of MEC and brain was measured by Mud boxb
based on the 3-dimensional reconstruction. Observers were
blinded to the clinical status.
The data were not normally distributed; therefore, descrip-
tive statistics using median and range were employed. The non-
parametric Kruskal-Wallis test was used to compare the volume
ratio between MEC and intracalvarial brain tissue in the 3
groups determined by subjective assessment (mild, moderate, and
severe). Mann-Whitney U-test was used as posthoc analysis to
determine differences between each group, by the statistical soft-
ware SPSSc.
Results
Clinical Features
Twenty-two dogs diagnosed with cranial MC or
MEC at 13 institutions met the inclusion criteria. The
age at time of diagnosis varied from 1 month to 8 years
(median, 6.5 months). The following breeds were repre-
sented: Jack Russell Terrier (3), Border Collie (2), Lab-
rador Retriever (2), Chihuahua (1), Weimaraner (1),
Toy Poodle (1), Malinois (1), Cocker Spaniel (1), Boxer
(1), Pointer (1), Cavalier King Charles Spaniel (1), Eng-
lish Springer Spaniel (1), Welsh sheepdog (1), miniature
Dachshund (1), and crossbreed dogs (4). Eleven of the
dogs were male (4 neutered), and 11 were female (2
spayed).
The most common presenting clinical signs were
epileptic seizures (n = 17, 77%) and abnormal behavior
(n = 7, 31%). Median duration of clinical signs before
presentation was 30 days (range, 12 hours – 1 year). In
1 dog (case 10), the meningoencephalocele was consid-
ered an incidental diagnostic imaging finding. The sig-
nalment and clinical signs of the patients are described
in Table S1.
Information regarding seizure characteristics was
available in 16 of 17 cases. Only generalized seizures
were present in 10 dogs (63%), 1 dog experienced focal
seizures (6%), and 5 dogs (31%) had both focal and
generalized seizures. Abnormal behavior was seen in 7
dogs (30%) and included aggressiveness (2), compulsive
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behavior (4), hyperactivity (2), intermittent yelping (2),
and star-gazing or fly-catching behavior (1).
Physical examination was normal in 17 dogs (77%).
Two dogs had an open fontanel, 1 dog had a dome-
shaped head, 1 dog had a facial deformity and right
nasolacrimal duct obstruction secondary to a dog bite,
and 1 dog had nasal discharge (suspected CSF rhinor-
rhea). Another dog developed suspected CSF rhinor-
rhea after diagnosis. Neurologic examination was
abnormal in 16 of 22 dogs (73%). One dog had a
concurrent neurologic disease (lymphoma). Abnormali-
ties in the neurologic examination in dogs without
concurrent disease (n = 15) consisted of decreased
mentation (n = 2, 13%), circling (n = 5, 33%), vestibu-
lar ataxia (n = 1, 7%; parietal meningocele), cerebellar
ataxia (n = 1, 7%; frontal and parietal meningocele),
proprioceptive deficits (lateralized [n = 9, 60%], bilat-
eral symmetric [n = 2, 13%]), absent or decreased men-
ace response (unilateral [n = 5, 33%], bilateral [n = 4,
27%]), unilateral decreased nasal sensation (n = 3,
20%), strabismus (n = 2, 14%), intermittent positional
nystagmus (n = 1, 7%; parietal meningocele), and
hyperesthesia of the head (n = 2, 13%) and cervical
spine (n = 1, 7%; parietal meningocele). Abnormal neu-
rologic examination findings are described in Tables
S2a and S2b.
In dogs with abnormal neurologic examination find-
ings (73%), the neuro-anatomic localization was to the
forebrain (bilateral in 3 cases [19%], lateralized in 9
cases [56%]), and to the cerebellum in 1 case (frontal
and parietal meningocele). Multifocal signs were seen in
2 dogs (13%; 1 with concurrent lymphoma and 1 with
syringomyelia), and in 1, the lesion was localized to
caudal cervical region (diagnosed with a presumably
unrelated cervical lesion consistent with focal myositis
or neuritis).
Magnetic Resonance Imaging Findings
Seventeen dogs were diagnosed with an intranasal
MEC (73%; Fig 1). The ethmoidal bone was affected in
15 dogs (68%). The frontal bone was affected in 2 dogs.
The parietal bone was affected in 6 of 22 dogs (27%).
One dog had a concurrent frontal MEC and parietal
MC (Fig 2). One dog was diagnosed with a frontal
MEC, which did not protrude into the sinus but later-
ally under the temporal muscle (Fig 3).
In all dogs in which the ethmoidal bone and frontal
bone were affected, neuronal tissue protruded through
the bone defect. Meninges alone appeared to protrude
through parietal bone defects. The protruding brain tis-
sue was hyperintense on T2w sequences in 14 of 17 cases,
with presence of fluid (isointense compared to CSF sig-
nal) in the meningeal sac in 6 of 17 dogs, and evidence of
hemorrhage in 6 of 13 dogs (GRE sequences performed
in 13 dogs). After IV administration of gadopentetate
dimeglumine, meningeal enhancement of the protruding
tissue was seen in 17 of 22 dogs on T1w images. Concur-
rent malformations were seen in 3 of 17 dogs with intra-
nasal lesions. Two dogs had severe ethmoidal MECs with
most likely compensatory hydrocephalus ex vacuo. Con-
current malformations were seen in all dogs with parietal
meningocele (porencephaly in 4 dogs, supracollicular
fluid accumulation in 1 dog). In the dog with frontal
MEC and parietal MC, several concurrent malforma-
tions were detected: hydrocephalus ex vacuo, possible
cerebellar hypoplasia, dilatation of the olfactory recess,
and porencephaly. The MEC or cranial MC was
A B C
Fig 1. Dorsal magnetic resonance images of the brain and nose of dogs with a mild (A), moderate (B), and severe (C) unilateral ethmoidal
meningoencephalocele. Short tau inversion recovery (A), T2-weighted sequence (B,C).
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unilateral in 19 of 22 dogs. The remaining brain tissue
showed asymmetry in 12 of 22 dogs. The MRI findings
are summarized in Table S3.
Subjective assessment of intranasal MEC size was
performed in 16 dogs (dog 22 was excluded based on
concurrent parietal MC). The MEC was considered
mild in 4 dogs, moderate in 7 dogs, and severe in 5
dogs. Overall, the calculated volume ratio between
MEC and intracalvarial brain was significantly different
in the 3 groups identified by subjective assessment of
the amount of protruded tissue (mild, moderate, and
severe; P = .009). Individual comparison among groups
identified a significant difference between the groups
moderate and severe (P = .028) and the groups mild
and severe (P = .014). The difference between the
groups mild and moderate was not statistically signifi-
cant (P = .059; Fig S2).
Results of CSF Analysis
Cerebrospinal fluid analysis was performed in 11
dogs. It was normal in 6 dogs (55%) and identified
abnormalities in 5 dogs (45%). One dog was diagnosed
with a concurrent condition (case 10, lymphoma). The
CSF analysis disclosed mild changes in 4 samples (in-
creased eosinophil count in 1 dog, mixed pleocytosis in
2 dogs, mildly increased protein concentration in 1
dog). All dogs with abnormal CSF and without concur-
rent disease had intranasal MECs. Results of CSF anal-
ysis are summarized in Table S4.
A B
C D
Fig 2. T2-weighted magnetic resonance images of the brain of dogs with meningoencephalocele and meningocele. A: midsagittal view of
the brain of a dog with a severe intranasal ethmoidal meningoencephalocele. B: transverse view of the brain at the level of the thalamus
depicting a unilateral parietal meningocele with associated porencephaly and asymmetry of the remaining brain tissue. C: midsagittal view
of the brain of a dog with frontal meningoencephalocele into the frontal sinus. D: dorsal view of the brain and nose of a dog with unilat-
eral parietal meningocele and intranasal frontal meningoencephalocele.
A B C
Fig 3. Transverse magnetic resonance imaging sequences of the forebrain of a dog with frontal meningoencephalocele, T2-weighted
sequence (A), T1-weighted sequence before contrast (B) and after intravenous contrast (C). Note the contrast enhancement of the pro-
truded meninges.
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Outcome
Eleven dogs were alive (50%), and 9 dogs were dead
(41%) at the time of writing. The outcome is unknown
in 2 cases. Four dogs were euthanized shortly after
diagnosis because of the severity of their clinical signs
(18%). One dog with parietal MC did not receive any
medication (alive at the last follow-up 8 weeks after
diagnosis). Medical treatment was started in 17 dogs.
Treatment consisted of anti-epileptic medication in 13
of 17 dogs (phenobarbital [n = 11], imepitoin [n = 3],
levetiracetam [n = 4], potassium bromide [n = 2], com-
bination of 2 anti-epileptic drugs (AED) or more
[n = 5]). Seven dogs were treated with a course of pred-
nisolone (variable anti-inflammatory doses, tapered over
a few weeks). Three dogs with inflammatory CSF find-
ings were treated with a course of antibiotics (amoxi-
cillin-clavulanic acid, metronidazole).
The follow-up period ranged from 2 months to
4 years, with a median of 365 days. In 11 dogs, the sei-
zures were controlled by anti-epileptic treatment at the
last follow-up. Five dogs were considered responders (2
dogs are seizure-free, 3 dogs had a seizure reduction of
≥50%), and in 6 dogs, an improvement of seizure fre-
quency was noted but follow-up data did not specify
whether seizure frequency was decreased by ≥50%. In 3
dogs, seizures were initially controlled by AED for a
duration of 1 and 4 years (unknown duration in 1 dog),
but they were euthanized at a later stage because of
uncontrolled seizures.
All 4 dogs in which the intranasal MEC was classified
as mild with MRI were alive at final follow-up (follow-
up period, 548 days – 1095 days; median, 730 days). In
7 dogs, the MECs were considered moderate. Three of
these dogs were euthanized (1 immediately after
diagnosis, 2 at a later stage because of uncontrolled sei-
zures), and 4 were still alive at the last follow-up. The
MECs were considered severe in 5 dogs, 4 of which
were euthanized (3 shortly after diagnosis, 1 was eutha-
nized 1 year after diagnosis because of uncontrolled sei-
zures). Treatment and outcome of all dogs are
summarized in Tables S5a and S5b and in Figure S7.
Gross and Histopathologic Findings
Necropsy was performed on 2 dogs. One dog (dog 1)
was euthanized shortly after diagnosis. One dog (dog 6)
was treated medically for 4 years and euthanized at
12 years of age because of recurrent seizures.
In both cases, the olfactory lobe protruded into the
nasal cavity through a closure defect in the cribriform
plate. The herniated olfactory lobe was composed of
necrotic neuronal tissue overlaid by a thick (approxi-
mately 1 mm) layer of mature collagenous connective
tissue (fibrosed dura), which in turn was covered by a
single layer of respiratory epithelium. Occasionally
expanding the dura were deposits of mineral (dystrophic
mineralization) and the dura blended with firm adher-
ence to the remaining cribriform plate (dog 6). There
was a distinct, approximately 1 cm, gap between the
herniated olfactory lobe and the dorsal nasal conchae
(dog 6). Infiltrating the neuropil of the olfactory lobe
were frequent oligodendrocytes and astrocytes (gliosis)
and proliferations of immature fibrovascular connective
tissue (neovascularization). Frequent pools of hemor-
rhage were present throughout (Fig 4).
The right frontal lobe adjacent to the protruded
olfactory lobe was chronically inflamed and edematous,
and in dog 6, these changes caused compression of the
A B
C
Fig 4. A: Unilateral ethmoidal meningoencephalocele (Arrow: Pronounced midline shift// Star: Abundant hemorrhage within the herni-
ated olfactory bulb). B: Herniated olfactory bulb (Large arrow: Respiratory epithelium/// Thin arrow: Neuropil// (940 Hematoxylin and
eosin) C: Herniated olfactory bulb ((Large arrow: Respiratory epithelium/// Thin arrow: Neuropil//) (9200 Hematoxylin and eosin).
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left frontal lobe and a pronounced midline shift. Under-
lying both lateral ventricles were small irregular
proliferations of fibrovascular connective tissue (neovas-
cularization).
Discussion
We describe 22 dogs with cranial MC, MEC, or both,
a rare condition with variable outcome. An MEC typi-
cally forms as a result of a congenital defect during the
closure of the neural tube but can also arise after
trauma.4 In human medicine, MECs developing as a
result of chronically increased intracranial pressure13 or
postsurgery14 have been described. Congenital MCs and
MECs have been reported in humans and various
domestic animals.15,16 A hereditary predisposition has
been shown in Burmese cats,16 but teratogenic factors
and nutritional deficiencies may play a role in the devel-
opment of such malformations.17,18 Based on the small
number of cases collected throughout Europe in this
study, it appears to be a sporadically occurring disease,
that might be underdiagnosed because diagnosis
requires advanced imaging and some dogs may not
have any neurologic signs, as occurred in the dog diag-
nosed with lymphoma and an incidental MEC. Early
head trauma could be a predisposing factor, as occurred
in at least 1 of the cases.
The MECs are classified according to the anatomic
localization of the skull defect.7 In the human literature,
the term encephalocele defines a cephalic hernia through
a skull defect and includes both MEC and MC.19 The
occipital region is the most common site of protrusion in
humans in Western regions,20 whereas, for unknown rea-
sons, fronto-ethmoidal encephaloceles are more common
in South-East Asia (1 : 5,000 live births21). Most of the
cases presented here were ethmoidal (15 of 22, 68%) and
intranasal (16 of 22, 73%). This finding does not neces-
sarily reflect the occurrence within the canine population
and may be explained by the fact that puppies with
severely debilitating diseases and obvious malformations
are likely to be euthanized at an early age. In humans,
the localization of the encephalocele has an important
impact on the prognosis for the patient,22 caudally
located lesions being associated with worse neurologic
signs and outcomes than rostrally located lesions.19
The protruded parenchyma was heterogeneously
hyperintense on T2w and FLAIR images in 14 dogs.
These findings could be consistent with gliosis of cere-
bral tissue, tissue inflammation, or edema. In 2 dogs,
histology of the protruded brain tissue indicated that
this tissue exhibited a paucity of neurons, multifocal
new vessel formation, and malacia. This observation
correlates with the results described in previous case
reports that identified gliosis and areas of malacia.3 In
humans, gliosis of the protruded tissue is a common
finding.23 In some cases, histopathology of the MEC in
humans showed fibrosis and chronic inflammation.24,25
Magnetic resonance imaging indicated that the pro-
truded meninges were associated with contrast enhance-
ment on T1w postcontrast images in 17 of 22 cases. This
finding could be consistent with focal meningitis or low
CSF pressure. Cerebrospinal fluid analysis was per-
formed in 12 dogs, and abnormal CSF findings did not
correlate with meningeal enhancement on MRI. In 10
dogs with meningeal enhancement, CSF was normal in 6
dogs and showed abnormalities in 4 dogs. In 1 dog, his-
tologic examination of the herniated tissue indicated
chronic meningitis, but meningeal enhancement of the
protruded tissue was not detected on MRI. Magnetic
resonance imaging had low sensitivity for diagnosis of
meningeal pathology in dogs when compared to histo-
logic findings.26 In 1 study, meningeal enhancement was
identified in only 28% of 25 dogs with inflammatory
CSF.27 In human medicine, meningeal enhancement of
pachymeninges on MRI, as well as venous sinus
engorgement and subdural effusions, has been associated
with intracranial hypotension.28,29 The same pathologi-
cal processes could explain the meningeal enhancement
in the patients presented here, because the brain is no
longer contained within an intact cranial vault, which
may impair CSF and intracranial volume homeostasis
(Monro-Kellie doctrine) in patients with cranial MC or
MEC.
Seizures were the main presenting neurologic sign in
most of the dogs with intranasal lesions. All dogs with
focal seizures had unilateral intranasal MECs. However,
8 dogs with unilateral intranasal MECs were reported
to only display generalized seizures. Only 1 dog with
parietal MC presented with seizures. This observation
reflects the neuro-anatomic localization of the lesion,
but seizure characteristics do not seem to be a reliable
indicator of the localization of the defect. In humans,
MECs are considered epileptic foci.30 This theory is
supported by the fact that surgical repair of MECs gen-
erally results in elimination of seizures.5,30,31 Several
hypotheses have been formulated regarding the patho-
physiology of seizures in encephalocele patients, includ-
ing irritative traction or herniation of involved cortex
or hemorrhage, malacia, degeneration white matter, and
inflammatory cell infiltrates contributing to abnormal
excitability of cortical neurons.3 Magnetic resonance
imaging and histopathology results in this study con-
firmed that the herniated tissue shows signs of inflam-
mation and hemorrhage.
Six dogs with intranasal MECs had normal neuro-
logic examination findings. Because even dogs with sev-
ere malformation may not show any deficits in
neurologic examination, MEC must be considered a
differential diagnosis for young dogs presenting
with seizures and unremarkable interictal neurologic
examination.
Seven dogs had asymmetrical neurologic deficits. The
MRI images of 6 of these dogs showed asymmetry of
the intracalvarial part of the cerebrum, which was con-
firmed histopathologically in dog 6. This phenomenon
has been described in humans with MEC.32 In addition
to mechanical traction by the herniated tissue and
decreased blood supply to specific areas,33 CSF flow
obstruction seems to play a role in the pathogenesis of
secondary malformations.32
In humans, the most common concurrent malforma-
tions found on MRI in patients with MEC were
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hydrocephalus (15%) and corpus callosum agenesis
(7%),34 with a direct relationship between the number
of intracranial abnormalities and the amount of herni-
ated brain.32 Agenesis of the corpus callosum has been
described in a cat with midline parietal MEC35 but not
in any of the dogs presented here. Interestingly, in this
study, porencephaly was seen in all dogs with parietal
MEC. The clinical and MRI characteristics of poren-
cephaly have been described previously in dogs, some
of which had evidence of parietal MC.36,37 Additional
studies are necessary to determine whether a causal
relationship exists between these conditions.
In human medicine, surgical intervention is the treat-
ment of choice, based on the potential for recurrent
meningitis, brain damage from herniation, and refrac-
tory seizures.38 Seizures stopped after surgical interven-
tion in 1 affected dog.5 However, in our study, 10 of 17
of dogs presented with seizures responded well to medi-
cal treatment with AED. Medical management seems to
be a viable treatment option for dogs with only mild
neurologic signs. Additional studies examining the long-
term outcome of dogs treated medically are required to
assess the risk for ascending meningitis in affected dogs.
The risk for ascending infection is an important indica-
tion for surgery in humans. Therefore, this risk needs to
be weighed against the invasiveness of surgical treat-
ment individually until additional studies are available
in veterinary medicine. Surgery may be considered in
dogs with CSF rhinorrhea or in those with refractory
seizures, although the outcome after surgery needs to be
evaluated in more cases to assess its benefits.
Case series in human medicine have shown that the
size and content of the protruding meningeal sac has an
impact on prognosis.11 At the last follow-up, all 4 dogs
subjectively categorized as mild, but only 4 of 7 dogs
with moderate MEC and 1 of 5 dog with severe MEC
were still alive. The size of the MEC as well as neuro-
logic signs may have played a role in the decision-
making process about euthanasia. Subjective assessment
based on MRI seems to be a reliable tool to determine
MEC size, but additional studies with larger numbers
of cases will be necessary to confirm this observation.
The limitations of our study are inherent in its retro-
spective multicenter nature. The distinction between
presumed acquired and congenital MEC or MC could
not be made in all cases based on historical informa-
tion, because information concerning the first weeks of
life was limited. The number of parietal MC was lim-
ited, and the imaging studies did not follow a specified
protocol. Furthermore, treatment protocol was at the
clinician’s discretion. Follow-up periods were variable,
and follow-up did not always include a neurologic
examination. Unfortunately, prospective evaluation of
an acceptable number of cases is difficult based on the
rarity of this condition.
Conclusion
Although uncommon, MEC should be considered as
a differential diagnosis in young dogs presenting with
seizures or alterations in behavior. Medical treatment is
a valid option with a fair prognosis when the MEC is
mild.
Footnotes
a Amira 5.3.3, Visage Imaging and ZIB, Germany
b Mud box 2016, Autodesk Inc.
c SPSS 17.0 for Windows, SPSS Inc.
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Supporting Information
Additional Supporting Information may be found
online in the supporting information tab for this article:
Figure S1. Three-dimensional reconstruction of the
intracalvarial brain (purple) and intranasal meningoen-
cephalocele (green) based on transverse, sagittal and
dorsal T2-weighted magnetic resonance imaging
sequences.
Figure S2. Box-and-whisker plot diagram representing
the subjective grading of MEC compared with ratio
between MEC volume and intracalvarial brain volume
in dogs with intranasal MEC.
Figure S3. Treatment and outcome in all cases.
Table S1. Overview of the signalment, presenting
complaint and diagnosis for all cases of MC/MEC.
Table S2a. Neurological signs and localization of
intranasal (ethmoidal and frontal) MEC after MRI.
Table S2b. Neurological signs and localization of
parietal/frontal MC/MEC.
Table S3. MRI findings in dogs with meningocele
and meningoencephalocele (Case 22 is mentioned twice
as it had an intranasal MEC and a parietal MC).
Table S4. Results of CSF analysis in dogs with
abnormal CSF examination.
Table S5a. Treatment and outcome of dogs with
intranasal (ethmoidal and frontal) MEC (case 22
excluded based on the concurrent parietal MC).
Table S5b. Treatment and outcome of dogs with pari-
etal/frontal MC/MEC and with concurrent intranasal
and parietal MC/MEC.
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